• Can America and Its Allies Tolerate A Nuclear Iran, or Is It Time to Stop Them Now?
    Jan 10 2025
    Iran is getting closer to developing its first nuclear weapon. With tensions rising in the Middle East, should the U.S. and its allies take a stand? Those calling to stop Iran now argue this is a “now or never” moment for the region. Those calling for tolerance say while it’s not ideal, it is manageable, and maintaining diplomacy should be the focus. Now we debate: Can America and Its Allies Tolerate A Nuclear Iran, or Is It Time to Stop Them Now? Arguing STOP NOW: Behnam Ben Taleblu, Senior Fellow at the Foundation for Defense of Democracies Arguing TOLERATE: Barbara Slavin, Distinguished Fellow at the Stimson Center Emmy award-winning journalist John Donvan moderates Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • Does AA Work?
    Jan 3 2025
    Millions of people have credited Alcoholics Anonymous with helping them stay sober from alcohol, but is it the best path for everyone? Those who say “yes” argue it is easily accessible to all and that its structure through the 12-step program helps people succeed. Those who say “no” argue say the abstinence model doesn’t work for everyone and there may be better alternatives. Now we debate: Does AA Work? Arguing Yes: Dan Griffin, Expert on Alcoholics Anonymous; Author of "A Man's Way Through the Twelve Steps" Arguing No: Adi Jaffe, Founder of IGNTD; Author of "The Abstinence Myth" Nayeema Raza, Journalist and Co-Host of the Semafor Podcast "Mixed Signals", is the guest moderator. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • Could Longevity Science Extend Your Health Span By Decades? Should the Government Fund It?
    Dec 27 2024
    How long would you like to live, and could science and technology make it possible? Longevity science aims to extend our healthy years through advancements in CRISPR, cellular reprogramming, and drug development. While private companies and philanthropists invest heavily in these innovations, should the government be responsible for funding these efforts? Those who say yes to government funding say that longevity research could revolutionize public health, keep aging populations productive in the workforce, and reduce the economic burden of age-related illnesses. Those opposed to public funding of longevity science say that true life extension beyond a decade might be unachievable, and it will take years before results are measurable. They argue that when and if these advances become available, they may only be for a smaller, affluent population. They also argue that long-known behavior choices like good nutrition and sleep should be adopted by all now, instead of chasing uncertain longevity advancements. With this context, we debate the question: Could Longevity Science Extend Your Health Span By Decades? Should the Government Fund It? Arguing Yes: Peter Diamandis, Founder and Chairman of the XPRIZE Foundation; Announced the XPRIZE Healthspan Competiton; Author of "Longevity Guidebook" Arguing No: Ezekiel J. Emanuel, Bioethicist; Vice Provost for Global Initiatives at the University of Pennsylvania Emmy award-winning journalist John Donvan moderates Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • The Pursuit of Happiness: Virtue or Pleasure?
    Dec 20 2024
    Happiness is a complex emotion and mental state that can be achieved through virtue or pleasure. But should it be for the good of the individual or society? Those in favor of virtue point to the Stoics and the Founding Fathers, saying you should strive for a life of moral virtue and rationality. Those in favor of pleasure say everyone should be able to experience it and define their sources of happiness. Now we debate: The Pursuit of Happiness: Virtue or Pleasure? Arguing Virtue: Jeffrey Rosen, CEO & President of the National Constitution Center; Author of “The Pursuit of Happiness: How Classical Writers on Virtue Inspired the Lives of the Founders and Defined America” Arguing Pleasure: Roger Crisp, Professor of Moral Philosophy at the University of Oxford; Uehiro Fellow and Tutor in Philosophy at St. Anne's College, Oxford Nayeema Raza, Journalist at New York Magazine and Vox, is the guest moderator. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • Psychedelics for Mental Health: Help or Hype?
    Dec 13 2024
    Some scientific studies have shown evidence that psychedelic drugs, when used in controlled therapeutic settings, may help patients with their mental health — but should they be recommended by your doctor? Those advocating for psychedelic use argue that it could be a welcome relief for patients who don’t respond to traditional medicine. Those against its use argue we don’t yet understand their long-term effects. Now we debate: Psychedelics for Mental Health: Help or Hype? Arguing Help: Ismail Ali, Director of Policy and Advocacy at MAPS Arguing Hype: Kevin Sabet, President and CEO at the Foundation for Drug Policy Solutions Emmy award-winning journalist John Donvan moderates Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • Global Leaders Debate Money, Truth, and Power
    Dec 6 2024
    From economic turbulence and the dilemmas posed by artificial intelligence to the big-picture challenges of our time, the pillars of money, truth, and power shape the complex global landscape. In partnership with the Future Investment Initiative (FII), join us as twelve of the world’s greatest thinkers debate: “Clash of the Titans: Three Grand Challenges Facing Humanity,” “What is Europe’s Economic Outlook?”, and “Will AI-Generated Entertainment Replace Human Creativity?” Emmy award-winning journalist John Donvan, Open to Debate CEO Clea Conner, and moderator and journalist Edie Lush moderate. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • Fast Fashion: Shop or Stop?
    Nov 29 2024
    Fast fashion has taken over the fashion industry, but is less expensive, trendy clothing really worth the purchase? Those who say to “stop” argue fast fashion harms the environment in many ways and exploits workers in countries with lax regulations. Those who say “keep shopping” argue it’s up to shoppers to choose, as fast fashion offers affordable options, supports jobs, and boosts local economies. Now we debate: Fast Fashion: Shop or Stop? Arguing Stop: Kenneth Pucker, Former COO of Timberland; Professor at The Fletcher School at Tufts University Arguing Shop: Katherine Mangu-Ward, Editor-in-Chief at Reason Emmy award-winning journalist John Donvan moderates Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins
  • Thinking Twice: Revenge of the Tipping Point with Malcolm Gladwell
    Nov 22 2024
    In 2000, New York Times bestselling author Malcolm Gladwell released the groundbreaking book “The Tipping Point: How Little Things Can Make a Big Difference”, which explored how small ideas can create lasting changes in everyday life through social engineering and the “tipping points” phenomenon. Two decades after the book’s original publication and in the spirit of an organizational mission that values a second look at seminal ideas, we speak with Gladwell about what he has learned and, in some cases, reconsidered. In this conversation with Open to Debate guest moderator Nayeema Raza, Gladwell discusses his sequel “Revenge of the Tipping Point: Overstories, Superspreaders, and the Rise of Social Engineering”, which looks at the darker side of social epidemics, what he thinks might have been wrong with some of his original theories, and how such thought evolution is a sign of growth. Our Guest: Malcolm Gladwell, Bestselling Author; Co-Founder of Pushkin Industries Nayeema Raza, Journalist and Co-Host of the Semafor Podcast “Mixed Signals”, is the guest moderator. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
    53 mins